Lista de obras - Marina Tadolini - Dominio Público Uruguay

A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium

artículo científico publicado en 2015

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

artículo científico publicado en 2016

Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.

artículo científico publicado en 2019

Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19

artículo científico publicado en 2020

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

artículo científico publicado en 2017

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

artículo científico publicado en 2018

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis

artículo científico publicado en 2018

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

artículo científico publicado en 2016

Compassionate and optimum use of new tuberculosis drugs.

artículo científico publicado en 2015

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges

artículo científico publicado en 2016

Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe

artículo científico publicado en 2016

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

artículo científico publicado en 2017

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

artículo científico publicado en 2020

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

artículo científico publicado en 2014

ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

artículo científico publicado en 2013

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

artículo científico publicado en 2016

Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature

artículo científico publicado en 2016

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

artículo científico publicado en 2016

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

artículo científico publicado en 2016

First independent evaluation of QuantiFERON-TB Plus performance.

artículo científico publicado en 2016

How to manage children who have come into contact with patients affected by tuberculosis

artículo científico publicado en 2015

Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment

artículo científico publicado en 2017

Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay

artículo científico publicado en 2017

Paediatric tuberculosis in Europe: lessons from Denmark and inclusive strategies to consider

artículo científico publicado en 2014

QuantiFERON-TB Performs Better in Children, Including Infants, than in Adults with Active Tuberculosis: a Multicenter Study

scientific article published on 24 September 2019

Recommendations Concerning the First-Line Treatment of Children with Tuberculosis

artículo científico publicado en 2015

Recommendations Concerning the Therapeutic Approach to Immunocompromised Children With Tuberculosis

artículo científico publicado en 2015

Recommendations for the diagnosis of pediatric tuberculosis

artículo científico

Recommendations for treating children with drug-resistant tuberculosis

artículo científico publicado en 2016

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe

article

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

scientific article published on 29 May 2019

Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphoma ⬇️

artículo científico publicado el 26 de septiembre de 2003

Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period

artículo científico publicado en 2003

Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease

artículo científico publicado en 2000

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

scientific article published on 03 April 2019

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

artículo científico publicado en 2019

TB and MDR-TB: what is new in 2012?

TB consilia and quality of tuberculosis management

scientific article published on 01 October 2019

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

artículo científico publicado en 2017

The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011.

artículo científico publicado en 2014

Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates.

artículo científico publicado en 2014

Tuberculosis elimination: theory and practice in Europe

artículo científico publicado en 2014

WHO strategies for the programmatic management of drug-resistant tuberculosis

artículo científico publicado en 2016

Lista de obras de Marina Tadolini

A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB consilium

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

Challenging MDR-TB clinical problems - The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs.

Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Combining bedaquiline and delamanid to treat multidrug-resistant tuberculosis

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Compassionate and optimum use of new tuberculosis drugs.

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges

Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe

Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review

Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study)

ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use.

ERS/WHO tuberculosis consilium: reporting of the initial 10 cases

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Efficacy, safety, and tolerability of a 24-month treatment regimen including delamanid in a child with extensively drug-resistant tuberculosis: A case report and review of the literature

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

First evaluation of QuantiFERON-TB Gold Plus performance in contact screening.

First independent evaluation of QuantiFERON-TB Plus performance.

How to manage children who have come into contact with patients affected by tuberculosis

Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment

Multidetector CT urography in urogenital tuberculosis: use of reformatted images for the assessment of the radiological findings. A pictorial essay

Paediatric tuberculosis in Europe: lessons from Denmark and inclusive strategies to consider

QuantiFERON-TB Performs Better in Children, Including Infants, than in Adults with Active Tuberculosis: a Multicenter Study

Recommendations Concerning the First-Line Treatment of Children with Tuberculosis

Recommendations Concerning the Therapeutic Approach to Immunocompromised Children With Tuberculosis

Recommendations for the diagnosis of pediatric tuberculosis

Recommendations for treating children with drug-resistant tuberculosis

Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphoma ⬇️

Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period

Silent oophoritis due to cytomegalovirus in a patient with advanced HIV disease

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

TB and MDR-TB: what is new in 2012?

TB consilia and quality of tuberculosis management

Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

The first population-based national tuberculosis prevalence survey in Ethiopia, 2010-2011.

Trend of microbiologically-confirmed tuberculosis in a low-incidence setting with high immigration rates.

Tuberculosis elimination: theory and practice in Europe

WHO strategies for the programmatic management of drug-resistant tuberculosis